Induction of clinical autoimmune disease by therapeutic interferon-α

Autoimmunity

Volumn 36, Issue 8, 2003, Pages 511-518

  Gota, Carmen ^a   Calabrese, Leonard ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIVIRUS AGENT; CHLOROQUINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETRETIN; ETRETINATE; HYDRALAZINE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROCAINAMIDE; RIBAVIRIN; STEROID; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UNCLASSIFIED DRUG;

ALOPECIA; AMINOTRANSFERASE BLOOD LEVEL; ANAPHYLACTOID PURPURA; APHTHOUS ULCER; ARTHRALGIA; ARTHROPATHY; AUTOIMMUNE DISEASE; AUTOIMMUNE HEPATITIS; BONE MARROW SUPPRESSION; CARCINOID; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CHILL; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; COGNITIVE DEFECT; CONNECTIVE TISSUE DISEASE; DEPRESSION; DIABETES MELLITUS; DIARRHEA; DISEASE EXACERBATION; DOSE RESPONSE; DRUG ERUPTION; DRUG FEVER; DRUG MEGADOSE; DRUG WITHDRAWAL; ENCEPHALITIS; ENTHESITIS; FATIGUE; FLU LIKE SYNDROME; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HEMATOLOGIC DISEASE; HEMOLYTIC ANEMIA; HEPATITIS C; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMPOTENCE; INFLAMMATION; INTERSTITIAL PNEUMONIA; KIDNEY DISEASE; LEUKOPENIA; LICHEN PLANUS; LIVER TOXICITY; LYMPHADENOPATHY; MENTAL DISEASE; MONARTHRITIS; MYALGIA; NAIL DYSTROPHY; NAUSEA; NEUROLOGIC DISEASE; NEUROTOXICITY; PANCREAS TUMOR; PERIPHERAL NEUROPATHY; PERNICIOUS ANEMIA; POLYARTHRITIS; POLYMYOSITIS; PSORIATIC ARTHRITIS; PSYCHOSIS; PUVA; RAYNAUD PHENOMENON; REITER SYNDROME; REVIEW; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SEIZURE; SJOEGREN SYNDROME; SKIN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TENOSYNOVITIS; THROMBOCYTOPENIA; THYROID DISEASE; VASOSPASM; VIRUS HEPATITIS; VITILIGO; VOMITING;

ARTHRITIS, PSORIATIC; ARTHRITIS, RHEUMATOID; HUMANS; INTERFERON-ALPHA; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 0345359586     PISSN: 08916934     EISSN: None     Source Type: Journal    
DOI: 10.1080/08916930310001605873     Document Type: Review

References (74)

1. Isaacs, A. and Lindenman, J. (1987) "Virus interference. I. The interferon", J. Interferon Res. 7, 429-438.
2. Cacoub, P. and Benhamou, Y. (2002) "Role of interferons in the treatment of hepatitis B and C virus infections", Rev. Med. Interne 23, 457-474.
3. Chandler, G., Sulkowski, M.S., Jenckes, M.W., Torbenson, M.S., Herlong, H.F., Bass, E.B. and Gebo, K.A. (2002) "Treatment of chronic hepatitis C: A systematic review", Hepatology 36, S135-S144.
4. O'Duffy, J.D., Calamia, K., Cohen, S., Goronzy, J.J., Herman, D., Jorizzo, J., Weyand, C. and Matteson, E. (1998) "Interferon-α treatment of Behcet's disease", J. Rheumatol. 25, 1938-1944.
5. Zeller, V., Cohen, P., Nguyen, Q.T., Lebon, P., Dziri, S., Ferrieri, F., Deny, P. and Guillevin, L. (2002) 20, 573-574.
6. Kalidas, M., Kantarjian, H. and Talpaz, M. (2001) "Chronic myelogenous leukemia", JAMA 286, 895-898.
7. Lacotte-Thierry, L. and Guilhot, F. (2002) "Intereferons and haematology", Rev. Med. Interne 23, 481s-488s.
8. Group, M.T.C. (2001) Br. J. Haematol. 113, 1020-1034.
9. Mey, U., Strehl, J., Gorschluter, M., Ziske, C., Glsmacher, A., Pralle, H. and Schmidt-Wolf, I. (2003) "Advances in the treatment of hairy-cell leukemia", Lancet Oncol. 4, 86-94.
10. Kirkwood, J. (2001) "Cancer immunotherapy: The interferon-α experience", Semin. Oncol. 29, 18-26.
11. Oberg, K. (2001) "Chemotherapy and biotherapy in the treatment of neuroendocrine tumours", Ann. Oncol. 12(2), S111-S114.
12. Fattovich, G., Giustina, G., Favarato, S. and Ruol, A. (1996) "A survey of adverse vents in 11,241 patients with chronic viral hepatitis treated with alfa interferon", J. Hepatol. 24, 38-47.
13. Okanoue, T., Sakamoto, S., Itoh, Y., Minami, M., Yasui, K., Sakamoto, M., et al. (1996) "Side effects of high-dose interferon therapy for chronic hepatitis, C", J. Hepatol. 24, 283-291.
14. Kirkwood, J.M., Bender, C., Agarwala, S., Tarhini, A., Shipe-Spotloe, J., Smelko, B., Donnelly, S. and Stover, L. (2002) "Mechanisms and management of toxicities associated with high-dose interferon alfa 2b therapy", J. Clin. Oncol. 20, 3703-3718.
15. Wandl, U.B., Nagel-Hiemke, M., May, D., Kreutzfelder, E., Kloke, O., Kranzhoff, M., Seeber, S. and Niederle, N. (1992) "Lupus-like autoimmune disease induced by interferon therapy for myeloproliferative disorders", Clin. Immunol. Immunopathol. 65, 70-74.
16. Quesada, J.R., Talpaz, M., Rios, A., Kurzrock, R. and Gutterman, J.U. (1986) "Clinical toxicity of interferons in cancer patients: A review", J. Clin. Oncol. 4, 234-243.
17. Ioannou, Y. and Isenberg, D. (2000) "Current evidence for the induction of autoimmune rheumatic manifestations by cytokine therapy", Arthritis Rheum. 43, 1431-1442.
18. Ronnblom, L.E., Alm, G.V. and Oberg, K.E. (1991) "Autoimmunity after α interferon therapy for malignant carcionoid tumors", Ann. Intern. Med. 115, 178-183.
19. Valenti, G., Mantelli, A., Persico, M., Tuccillo, C., Del Vechio Blanco, G., Morisco, F., et al. (1999) "Serologic and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions", Clin. Exp. Rheumatol. 17, 75-79.
20. Clifford, B.D., Donahue, D., Smith, L., Cable, E., Luttig, B., Manns, M., et al. (1995) "High prevalence of serologic markers of autoimmunity in patients with chronic hepatitis", C. Hepatol. 21, 613-619.
21. Reddy, K.R., Krawitt, E., Radick, J., Chastenay, B., De Medina, M., Jeffers, L.J., Parker, T., et al. (1993) "Absence of LKM1 antibody in hepatitis C viral infection in the United States (abstract)", Hepatology 18, 173A.
22. Czaja, A.J., Carpenter, H., Santrach, P.J., Moore, S.B., Taswell, H.F. and Homburger, H.A. (1993) "Evidence against hepatitis viruses as important causes of severe autoimmune hepatitis in the United States", J. Hepatol. 18, 342-352.
23. Hooks, J.J., Moutsopoulos, H.M., Geis, S.A., Stahl, N.I., Decker, J.L. and Notkins, A.L. (1979) "Immune interferon in the circulation of patients with autoimmune disease", N. Engl. J. Med. 301, 5-8.
24. Ytterberg, S.R. and Schnitzer, T. (1982) "Serum interferon levels in patients with systemic lupus erythematosus", Arthritis Rheum. 25, 401-406.
25. Ronnblom, L.E. and Alm, G.V. (2003) "Systemic lupus erythematosus and type I interferon system", Arthritis Res. Ther. 5, 68-75.
26. Ehrenstein, M.R., McSweeny, E., Swane, M., Worman, C.P., Goldstone, A.H. and Isenberg, D.A. (1993) "Appearance of anti-DNA antibodies in patients with interferon alfa", Arthritis Rheum. 36, 279-280.
27. Kalkner, K.M., Ronblom, L., Karlsson Parra, A.K., Bengtsson, M., Olsson, Y. and Oberg, K. (1998) "Antibodies against double-stranded DNA and development of polymyositis during treatment with interferon", QJM 91, 393-399.
28. Ronnblom, L.E., Alm, G.V. and Oberg, K.E. (1991) "Autoimmunity after α interferon therapy for malignant carcionoid tumors", Ann. Intern Med. 115, 178-183.
29. Sacchi, S., Kantarjian, H., O'Brien, S., Cohen, P.R., Pierce, S. and Talpaz, M. (1995) "Immune-mediated and unusual complications during interferon alfa therapy in chronic myelogenous leukemia", J. Clin. Oncol. 13, 2401-2407.
30. McCarthy, D.J., Manzi, S. and Medsger, T.A., Jr. (1995) "Incidence of systemic lupus erythematosus. Race and gender differences", Arthritis Rheum. 38, 1260.
31. Wilson, L.E., Widman, D., Dikman, S.H. and Gorevic, P.D. (2002) "Autoimmune disease complicating antiviral therapy for hepatitis C virus infection", Semin. Arthritis Rheum. 32, 163-173.
32. Stastny, P. (1978) "Association of B-cell alloantigen DRw4 with rheumatoid arthritis", N. Engl. J. Med. 298, 869-871.
33. Shiozawa, S., Chihara, K. and Shiozawa, K. (1986) "A sensitive radioimmunoassay for alfa interferon: Circulating alfa interferon like substance in the plasma of healthy individuals and RA patients", Clin. Exp. Immunol. 66, 77-87.
34. Shiozawa, S., Shiozawa, K., Kita, M., Kishida, T., Fujita, T. and Imuar, S. (1992) "A preliminary report on the effect of alfa-interferon treatment on the joint inflammation and serum calcium in rheumatoid arthritis", Br. J. Rheumatol. 31, 405-408.
35. Ardicoglu, O., Koseoglu, F. and Koka, I. (1993) "Lack of effect of recombinant alfa interferon in the treatment of rheumatoid arthritis", Scand. J. Rheumatol. 22, 204-205.
36. Levesque, M.C., Ward, F.E., Jeffrey, D.R. and Weinberg, J.B. (1999) "Interferon beta induced polyarthritis in a patient with the HLA-DRB1 *0404 allele", Arthritis Rheum. 42, 569-573.
37. Nesher, G. and Ruchlemer, R. (1998) "Alpha-interferon -induced arthritis: Clinical, presentation, treatment and prevention", Semin. Arthritis Rheum. 27, 360-365.
38. Chan, G.C., Lee, S.S. and Yeah, E.K. (1997) "Monoarthritis in a chronic hepatitis B patient after α interferon treatment", J. Gastroenterol. Hepatol. 7, 432-433.
39. Lombardini, F., Taglione, E., Riente, L. and Pasero, G. (1997) "Psoriatic arthritis with spinal involvement in a patient receiving α-interferon for chronic hepatitis C", Scand. J. Rheumatol. 26, 58-63.
40. Weiland, C.M. and Goronzy, J.J. (1997) "Pathogenesis of rheumatoid arthritis", Med. Clin. North Am. 81, 29-55.
41. De Maeyer, E. and De Maeyer-Guignard, J. (1998) "Type I interferons", Int. Rev. Immunol. 17, 53-73.
42. Passos De Souza, E., Teles Evangelista Secundo, P., Freire Jose, F., Lemaire, D. and Santiago, M. (2001) "Rheumatoid arthritis induced by α-interferon therapy", Clin. Rheumatol. 20, 297-299.
43. Hartmann, F.V., Wussow, P. and Deicher, H. (1989) "Psoriasis-Exazerbation bei therapie mit α-interferon", Dtsch. Med. Wschr. 114, 96-98.
44. Nguyen, C., Misery, L., Tigaud, J.D., Petiot, A., Fiere, D., Fuare, M. and Claudy, A. (1996) "Psoriasis induced by interferon-α. Apropos of a case", Ann. Med. Interne 147, 519-521.
45. Shiohara, T., Kobayshi, M., Kimiaki, A. and Nagashima, M. (1988) "Psoriasis occuring predominantly on warts", Arch. Dermatol. 124, 1816-1821.
46. Taylor, C., Burns, D.A. and Wiselka, M.J. (2000) "Extensive psoriasis induced by interferon alfa treatment for chronic hepatitis C", Postgrad. Med. J. 76, 365-366.
47. Rahamimov R., Klaus, S. and Tur-Kaspa, R. (1994) "Psoriasis is not a contraindication for α interferon treatment in patients with chronic hepatitis C", Acta Dermato-Venereol. (Stockh) 75, 86.
48. Pauluzzi, P., Kokelj, F., Perkan, V., Pozzato, G. and Moretti, M. (1993) "Psoriasis exacerbation induced by interferon - Alfa. Report of two cases", Acta Dermato-Venereol. (Stockh) 73, 395.
49. Georgeston, M.J., Yarze, J.C., Lalos, A.T., Webster, G.F. and Martin, P. (1993) "Exacerbation of psoriasis due to interferon - α treatment of chronic active hepatitis", Am. J. Gastroenterol. 88, 1756-1758.
50. Erkek, E., Karaduman, A., Akcan, Y., Sokmensuer, C. and Bukulmez, G. (2000) "Psoriasis associated with HCV and exacerbated by interferon α: Complete clearance with acitretin during interferon α treatment for chronic active hepatitis", Dermatology 201, 179-180.
51. Garcia-Lora, E., Tercedor, J., Massare, E., Lopez-Nevot, M.A., Skiljo, M. and Garcia-Mellado, V. (1993) "Interferon-induced psoriasis in a patient with chronic hepatis C", Dermatology 187, 280.
52. Wolfe, J.T., Singh, A., Lessin, S.R., Jaworsky, C. and Rook, A.H. (1995) "De nova development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma", J. Am. Acad. Dermatol. 33, 887-893.
53. Matsuoka, H., Uno, H., Nakama, N., Maeda, K. and Tsubouchi, H. (1994) "Psoriasis exacerbated by α-interferon therapy in a case of chronic myelogenous leukemia (abstract)", Rinsho Ketsueki 35, 309-311.
54. Neumann, R., Pohl-Markl, H. and Aberer, E. (1987) "Parenteral interferon - α treatment of psoriasis", Dermatologica 175, 23-28.
55. Moller, D.R. (1997) "Etiology of sarcoidosis", Clin. Chest Med. 18, 695-706.
56. Pietropaoli, A., Modrak, J. and Utell, M. (1999) "Interferon-α therapy associated with the development of sarcoidosis", Chest 116, 569-571.
57. Hoffmann, R.M., Jung, M-C., Motz, R., Gobl, C., Emslander, H-P., Zachoval, R. and Pape, G.R. (1998) "Sarcoidosis associated with interferon-α therapy for chronic hepatis C", J. Hepatol. 28, 1058-1063.
58. Fiorani, C., Sacchi, S., Bonacorsi, G. and Cosenza, M. (2000) "Systemic sarcoidosis associated with interferon-α treatment for chronic myelogenous leukemia", Haematologica 85, 1006-1007.
59. Nawras, A., Alsolaiman, M.M., Mehboob, S., Bartholomew, C. and Maliakkal, B. (2002) "Systemic sarcoidosis presenting as a granulomatous tatoo reaction secondary to interferon-α treatment for chronic hepatitis C and review of literature", Dig. Dis. Sci. 47, 1627-1631.
60. Tahan, V., Ozseker, F., Guneylioglu, D., Baran, A., Ozaras, R., Mert, A., Ucisik, A.C., Cagatay, T., Yilmazbayhan, D. and Senturk, H. (2003) "Sarcoidosis after use of interferon for chronic hepatitis C", Dig. Dis. Sci. 48, 169-173.
61. Vander Els, N.J. and Gerdes, H. (2000) "Sarcoidosis and IFN-α treatment", Chest 117, 294.
62. Wendling, J., Descamps, V., Grossin, M., et al. (2002) "Sarcoidosis during combined interferon α and ribavirin therapy in 2 patients with chronic hepatitis C", Arch. Dermatol. 138, 546-547.
63. Cleveland, M.G. and Mallory, S.B. (1993) "Incomplete Reiter's syndrome induced by systemic interferon treatment", J. Am. Acad. Dermatol. 29, 788-789.
64. Schapira, D., Nahir, A.M. and Hadad, N. (2002) "Interferon-induced Raynaud's Syndrome", Semin. Arthritis Rheum. 32, 157-162.
65. Lee, S-W., Kim, K-C., Oh, D-H., Jung, S-S., Yoo, D-H., Kim, S.Y., Choe, G. and Kim, T-H. (2002) "A case of polymyositis with dilated cardiomyopathy associated with interferon α treatment for hepatitis B", J. Korean Med. Sci. 17, 141-143.
66. Piqueras Alcol, B., De Diego Lorenzo, A., Perez Roidan, F., Banos Diaz, E. and Clemente Ricote, G. (1996) "Interferon-α and development of psoriatic arthropathy", An. Med. Interna. 13, 512-513.
67. Ilyas, W., Myers, D., Mann, R. and Seraly, M.P. (1999) "Remission of psoriasis after treatment with interferon-alfa and 2-chlordeoxyadenosine for hairy cell leukemia", J. Am. Acad. Dermatol. 40, 316-318.
68. Downs, A.M. and Dunnill, M.G. (2000) "Exacerbation of psoriasis by interferon-α therapy for hepatitis", Clin. Exp. Dermatol. 25, 351-352.
69. Jucgla, A., Marcoval, J., Curco, N. and Servitje, O. (1991) "Psoriasis with articular involvement induced by interferon alfa", Arch. Dermatol. 127, 910-911.
70. Olivieri, I., Padula, A., Ciancio, J. and La Civita, L. (2001) "Psoriatic arthritis and α-interferon", Scand. J. Rheumatol. 30, 175.
71. Germain, P., Delbrel, X., Traissac, T., Etienne, G., Lacoste, D., Le Bras, M. and Longy-Boursier, M. (199) "Rhumatisme psoriatique sous interferon α reversible a l'arret du traitment", Presse Med. 28, 2226-2227.
72. Spadero, A., Riccieri, V., Nisi, A. and Taccari, E. (1993) "IgM rheumatoid factor occurrence with recurrence of polyarthritis and psoriasis treatment with interferon α", Revue du Rhumatisme 60, 376-377.
73. Kusec, R., Ostrojic, S., Planinc-Peraica, A., Minigo, H. and Jaksic, B. (1990) "Exacerbation of psoriasis after treatment with α-interferon", Dermatologica 181, 170.
74. Makino, Y., Tanaka, R., Nakamura, K., et al. (1994) "Arthritis in a patient with Ps after interferon α therapy for chronic hepatitis C", J. Rheumatol. 21, 1771-1772.